Quality prescribing for chronic pain: guide for improvement 2026-2029

23. References

1 International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021 Definitions of Chronic Pain Syndromes - International Association for the Study of Pain (IASP)

2 Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing. 3rd ed. Scottish Government; 2018.

3 Royal Pharmaceutical Society, Pharmacy’s Role in Climate Action and Sustainable Healthcare

4 Department of Health and Social Care, Good for you, good for us, good for everybody A plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions, 2021.

5Tennison I., Roschnik S., Ashby B., et al. Health care's response to climate change: a carbon footprint assessment of the NHS in England. Lancet Planet Health. 2021;5(2):e84-e92. doi:10.1016/S2542-5196(20)30271-

6 Bussières A., Hancock M.J., Elklit A., et al. Adverse childhood experience is associated with an increased risk of reporting chronic pain in adulthood: a systematic review and meta-analysis. Eur J Psychotraumatol. 2023;14(2):2284025. doi:10.1080/20008066.2023.2284025

7 IASP Terminology. 2023.Terminology | International Association for the Study of Pain

8 El-Boghdadly K., Levy N.A., Fawcett W.J., et al. Peri-operative pain management in adults: a multidisciplinary consensus statement from the Association of Anaesthetists and the British Pain Society. Anaesthesia. 2024;79(11):1220-1236. doi:10.1111/anae.16391

9 van Rysewyk S., Blomkvist R., Chuter A., et al. Understanding the lived experience of chronic pain: A systematic review and synthesis of qualitative evidence syntheses. Br J Pain. 2023;17(6):592-605. doi:10.1177/20494637231196426

10 Torrance N., Veluchamy A., Zhou Y., et al. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. Br J Anaesth. 2020;125(2):159-167. doi:10.1016/j.bja.2020.05.017

11 Muller S, Bailey J, Bajpai R, et al. Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study. Pain. 2024;165(10):2282-2290. doi:10.1097/j.pain.0000000000003239

12 Craig, K. D., Holmes, C., Hudspith, M., et al. (2019). Pain in persons who are marginalized by social conditions. Pain, 161(2)10.1097/j.pain.0000000000001719

13 Macgregor, C., Walumbe, J., Tulle, E., et al. (2023). Intersectionality as a theoretical framework for researching health inequities in chronic pain. British Journal of Pain, 17(5)10.1177/20494637231188583

14 Scottish Government. (2023). Scottish Health Survey 2022 main report – volume 1.

15 Miall, N., Fergie, G., & Pearce, A., Health Inequalities in Scotland: trends in deaths, health and wellbeing, health behaviours, and health services since 2000. University of Glasgow, 2022. 10.36399/gla.pubs.282637

16 McCartney, G., Popham, F., McMaster, R., et al., Defining health and health inequalities. Public Health, 2019; 172, 22–30. 10.1016/j.puhe.2019.03.023

17 Scottish Intercollegiate Guidelines Network (SIGN), Management of Chronic Pain SIGN 136, 2019.

18 National Institute for Health and Clinical Excellence NG193, Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain 2021

19 National Institute of Health and Care Excellence (NICE), Clinical Knowledge Summaries, Chronic pain, January 2025

20 Faculty of Pain Medicine of the Royal College of Anaesthetists, Core standards for pain management services in the UK, 2021

21 National Institute of Health and Care Excellence (NICE), Clinical Knowledge Summaries, Red flag signs and symptoms, January 2025

22 Bennett M.I., Smith B.H., Torrance N., Potter J., The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6(3):149-158. doi:10.1016/j.jpain.2004.11.007

23 Cartagena Farias J., Porter L., McManus S. et al. (2017) Prescribing patterns in dependence forming medicines. London: NatCen.

24 Drug-related deaths in Scotland in 2023 - National Records of Scotland (NRS)

25 James J. Dealing with drug-seeking behaviour. Aust Prescr. 2016;39(3):96-100. doi:10.18773/austprescr.2016.022

26 National Institute for Health and Clinical Excellence NG64 Drug misuse prevention: targeted interventions. 2017

27 McCracken L.M., Learning to live with the pain: acceptance of pain predicts adjustment in persons with chronic pain. Pain. 1998;74(1):21-27. doi:10.1016/S0304-3959(97)00146-2

28 Chen Y., Sun J., Li Y., et al. Pain Acceptance: A Concept Analysis. Pain Manag Nurs. Published online March 8, 2025. doi:10.1016/j.pmn.2025.02.009

29 Williams A.C., Eccleston C., Morley S., Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012;11(11):CD007407. Published 2012 Nov 14. doi:10.1002/14651858.CD007407.pub3

30 Rosser B.A., Fisher E., Janjua S., et al. Psychological therapies delivered remotely for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2023;8(8):CD013863. Published 2023 Aug 29. doi:10.1002/14651858.CD013863.pub2

31 Hilton L., Hempel S., Ewing B.A., et al. Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis. Ann Behav Med. 2017 Apr;51(2):199-213. doi: 10.1007/s12160-016-9844-2. PMID: 27658913; PMCID: PMC5368208.

32 Skelly A.C., Chou R., Dettori J.R., et al. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update. Rockville (MD): Agency for Healthcare Research and Quality (US); April 2020.

33 Franqueiro A.R., Yoon J., Crago M.A., et al., The Interconnection Between Social Support and Emotional Distress Among Individuals with Chronic Pain: A Narrative Review. Psychol Res Behav Manag. 2023 Oct 27;16:4389-4399.

34 Whibley D., AlKandari N., Kristensen K., et al. Sleep and Pain: A Systematic Review of Studies of Mediation. Clin J Pain. 2019;35(6):544-558. doi:10.1097/AJP.0000000000000697

35 Mork P.J., Nilsen T.I., Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum. 2012;64(1):281-284. doi:10.1002/art.33346

36 Whale K., Dennis J., Wylde V., et al. The effectiveness of non-pharmacological sleep interventions for people with chronic pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2022;23(1):440. Published 2022 May 11. doi:10.1186/s12891-022-05318-5

37 Scottish Intercollegiate Guidelines Network (SIGN), SIGN 173 Management of chronic pain (part 1), 2025. (last accessed 10 February 2026)

38 de Zoete R.M., Armfield N.R., McAuley J.H., et al. Comparative effectiveness of physical exercise interventions for chronic non-specific neck pain: a systematic review with network meta-analysis of 40 randomised controlled trials. Br J Sports Med. Published online November 2, 2020. doi:10.1136/bjsports-2020-102664

39 Brain K., Burrows T.L., Rollo M.E., et al. A systematic review and meta-analysis of nutrition interventions for chronic noncancer pain. J Hum Nutr Diet. 2019;32(2):198-225. doi:10.1111/jhn.12601

40 Gregori D., Giacovelli G., Minto C., et al. Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. Jama. 2018;320(24):2564-79.

41 Wilson M.V., Braithwaite F.A., Arnold J.B., et al. The effectiveness of peer support interventions for community-dwelling adults with chronic musculoskeletal pain: a systematic review and meta-analysis of randomised trials. Pain. 2024;165(12):2698-2720. doi:10.1097/j.pain.0000000000003293

42 UK Government, Medicines and Healthcare Products Regulatory Agency, Drug Safety Update, 2020 Opioids: risk of dependence and addiction

43 Public Health England, 2019. Dependence and withdrawal associated with some prescribed medicines. London [online]

44 Derry, S., Bell, R.F., Straube, S., et al. Pregabalin for neuropathic pain in adults. 2019, Cochrane Database of Systematic Reviews, (1).

45 National Institute for Health and Care Excellence (NICE) Low back pain and sciatica in over 16s: assessment and management [NG59] 2020

46 McDonagh M.S., Selph S.S., Buckley D.I., et al. Nonopioid pharmacologic treatments for chronic pain. Rockville (MD): Agency for Healthcare Research and Quality (US); April 2020.

47 National Institute for Health and Care Excellence (NICE) Osteoarthritis in over 16s: diagnosis and management October 2022

48 Roberts E., Delgado Nunes V., Buckner S., et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552-559. doi:10.1136/annrheumdis-2014-206914

49 British National Formulary 2025

50 British National Formulary Treatment Summary: Non-steroidal anti-inflammatory drugs

51 Richards, D. The Oxford Pain Group League table of analgesic efficacy. Evid Based Dent 5, 22–23 (2004). https://doi.org/10.1038/sj.ebd.6400237

52 Derry, S., Wiffen, P.J., Häuser, W., et al. Oral nonsteroidal anti‐inflammatory drugs for fibromyalgia in adults. 2017. Cochrane Database of Systematic Reviews, (3).

53 Korownyk, C.S., Montgomery, L., Young, J., et al. PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care. 2022. Canadian Family Physician, 68(3), pp.179-190

54 Cashin, A.G., Wand, B.M., O'Connell, N.E., et al. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. 2023. Cochrane Database of Systematic Reviews, (4).

55 Wiffen P.J., Xia J., Systematic review of topical diclofenac for the treatment of acute and chronic musculoskeletal pain. Current medical research and opinion 2020;36(4):637-50.

56 AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023; 71(7): 2052-2081. doi:10.1111/jgs.18372

57 Specialist Pharmacy Service Using NSAIDs in asthma July 2024

58 Nury, E., Schmucker, C., Nagavci, B., et al. Efficacy and safety of strong opioids for chronic noncancer pain and chronic low back pain: a systematic review and meta-analyses. Pain, 2022;163(4), pp.610-636.

59 Petzke, F., Klose, P., Welsch, P., et al. Opioids for chronic low back pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks of double‐blind duration. European Journal of Pain, 2020; 24(3), pp.497-517.

60 Chou R., Hartung D., Turner J., et al. Opioid Treatments for Chronic Pain. Agency for Healthcare Research and Quality 2020:04

61 Noori A., Sadeghirad B., Wang L. et al. Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials. British Journal of Anaesthesia 2022;129:394-406.

62 Chou R., Selph S., Wagner J. et al. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1. Rockville, MD: Agency for Healthcare Research and Quality; 2022.

63 Chou R., Selph S., Wagner J. et al, Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2. Rockville, MD: Agency for Healthcare Research and Quality; 2022.

64 Chou R., Selph S., Wagner J. et al. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3. Rockville, MD: Agency for Healthcare Research and Quality; 2022.

65 Dowell D., Ragan K.R., Jones C.M., et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep 2022;71(3):1-95

66 Faculty of Pain Medicine, Opioids Aware

67 Jani M., Girard N., Bates D.W., et al. Comparative risk of mortality in new users of prescription opioids for noncancer pain: results from the International Pharmacosurveillance Study. Pain 2024.

68 Bedson J., Chen Y., Ashworth J., et al. Risk of adverse events in patients prescribed long-term opioids: A cohort study in the UK Clinical Practice Research Datalink. Eur J Pain 2019;23(5):908-22.

69 NHS Inform, Chronic Pain

70 Mattia C., Luongo L., Innamorato M., et al. An Italian expert consensus on the use of opioids for the management of chronic non-oncological pain in clinical practice: focus on buprenorphine. Journal of Pain Research. 2021;14(3193-3206.

71 Elmoheen, A., Nazal, A.F., Zubaidi, O., et al. Expert review and recommendations for the management of acute, chronic, and neuropathic pain in Qatar. Qatar Medical Journal, 2021(2), p.19.

72 Nagar V.R., Birthi P., Salles S., Sloan P.A., Opioid Use in Chronic Pain Patients with Chronic Kidney Disease: A Systematic Review. Pain medicine (Malden, Mass) 2017;18:1416–49

73 Chou, R., Turner, J.A., Devine, E.B., et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. 2015. Annals of internal medicine, 162(4), pp.276-286.

74 Colvin, L.A. and Fallon, M.T., 2010. Opioid-induced hyperalgesia: a clinical challenge. British journal of anaesthesia, 104(2), pp.125-127.

75 Daniell, H.W., 2002. Hypogonadism in men consuming sustained-action oral opioids. The Journal of Pain, 3(5), pp.377-384.

76 Daniell, H.W., 2008. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. The Journal of Pain, 9(1), pp.28-36.

77 Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression - GOV.UK

78 UK Government, Medicines and Healthcare Products Regulatory Agency, Drug Safety Update 2017. Gabapentin (Neurontin): risk of severe respiratory depression.

79 UK Government, Medicines and Healthcare Products Regulatory Agency, Drug Safety Update, 2021. Pregabalin (Lyrica)): reports of severe respiratory depression.

80 US Food and Drug Administration, Drug safety communication: FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder, 2020

81 Birkinshaw H., Friedrich C.M., Cole P., et al. Antidepressants for pain management in adults with chronic pain: a network meta-analysis. Cochrane Database of Systematic Reviews 2023;5:CD014682.

82 Welsch P., Üçeyler N., Klose P., et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database of Systematic Reviews 2018(2).

83 Fenske, J.N., Berland, D.W., Chandran, S., et al. Ambulatory Pain Management Guideline 2021, University of Michigan

84 Mair A., Fernandez-Limos F., Alonso A., et al. Polypharmacy Management by 2030: a patient safety challenge, 2nd Edition. Coimbra: SIMPATHY Consortium, 2017.

85 Migliorini F., Maffulli N., Eschweiler J., et al. The pharmacological management of chronic lower back pain. Expert opinion on pharmacotherapy. 2021;22(1):109-119.

86 Scottish Government Quality prescribing for antidepressants: guide for improvement 2024 to 2027 - gov.scot

87 Taylor, D.M., Barnes, T.R. and Young, A.H., 2021. The Maudsley prescribing guidelines in psychiatry. John Wiley & Sons.

88 Enke, O., New, H.A., New, C.H., et al. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. 2018. Cmaj, 190(26), pp.E786-E793.

89 Centre for Clinical Practice at NICE (UK, 2013. Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings [Internet]. Updated 2020

90 Moore, R.A., Wiffen, P.J., Derry, S. and Rice, A.S., 2014. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane database of systematic reviews, (4).

91 Wiffen P.J., Derry S., Moore R.A. and Kalso E.A., Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD005451. DOI: 10.1002/14651858.CD005451.pub3. Accessed 21 May 2025.

92 UK Government, Medicines and Healthcare Products Regulatory Agency, Drug Safety Update, 2021. Pregabalin (Lyrica): findings of safety study on risks during pregnancy.

93 Falk, J., Thomas, B., Kirkwood, J., et al. 2021. PEER systematic review of randomized controlled trials: Management of chronic neuropathic pain in primary care. Canadian Family Physician, 67(5), pp.e130-e140. available at: PEER systematic review of randomized controlled trials | The College of Family Physicians of Canada

94 Derry S., Rice A.S., Cole P., et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;1(1):CD007393. Published 2017 Jan 13. doi:10.1002/14651858.CD007393.pub4

95 Specialist Pharmacy Service: Use of nefopam for chronic pain, January 2024

96 Richards B.L., Whittle S.L., Buchbinder R.. Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2012;1(1):CD008921. Published 2012 Jan 18. doi:10.1002/14651858.CD008921.pub2

97 Stockings E., Campbell G., Hall W.D., et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 2018 Oct;159(10):1932-1954. DOI: 10.1097/j.pain.0000000000001293. PM

98 Dykukha I., Malessa R., Essner U. and Überall M.A., Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials. Pain Medicine. 2021;22(4):861-74.

99 Johal H., Devji T., Chang Y., et al., Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2020;13:1179544120906461.

100 McDonagh M.S., Morasco B.J., Wagner J., et al., Cannabis-based products for chronic pain: a systematic review. Annals of internal medicine. 2022;175(8):1143-53.

101 McParland A.L., Bhatia A., Matelski J., et al., Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. Regional Anesthesia & Pain Medicine. 2023;48(4):180-90.

102 Mücke M., Phillips T., Radbruch L., et al., Cannabis‐based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews. 2018(3).

103 Wang L., Hong P.J., May C., et al,. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ. 2021;374.

104 IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement. PAIN 162():p S1-S2, July 2021.

105 British Pain Society Position statement on the medicinal use of cannabinoids in pain management October 2018

106 Wong S.S.C., Chan W.S., Cheung C.W., Analgesic effects of cannabinoids for chronic non-cancer pain: a systematic review and meta-analysis with meta-regression. Journal of Neuroimmune Pharmacology. 2020;15:801-29.

107 Chou, R., Ahmed, A.Y., Dana, T., et al. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update

108 National Records of Scotland 2025. Drug-related deaths in Scotland in 2024. (last accessed 6 January 2026)

109 Lu, C.B., Liu, P.F., Zhou, Y.S., et al., Musculoskeletal pain during the menopausal transition: A systematic review and meta‐analysis. 2020, Neural plasticity, 2020(1), p.8842110.

110 Oxford University Hospitals Pain Management Centre, Guidance for opioid reduction in primary care, October 2023

111 Audi S., Burrage D.R., Lonsdale D.O., et al. The 'top 100' drugs and classes in England: an updated 'starter formulary' for trainee prescribers. Br J Clin Pharmacol. 2018;84(11):2562-2571. doi:10.1111/bcp.13709

112 Levy N., Lord L.J., Lobo D.N., UK recommendations on opioid stewardship. BMJ. 2021;372:m4901. Published 2021 Jan 5. doi:10.1136/bmj.m4901

113 Simpson A.K., Levy N., Mariano E.R., Opioid stewardship. BJA Educ. 2023;23(10):389-397. doi:10.1016/j.bjae.2023.05.007

114 Shrestha S., Khatiwada A.P., Sapkota B., et al. What is "Opioid Stewardship"? An Overview of Current Definitions and Proposal for a Universally Acceptable Definition. J Pain Res. 2023;16:383-394. Published 2023 Feb 10. doi:10.2147/JPR.S389358

115 Faculty of Pain Medicine: Opioids Aware – Patient assessment

116 Right Decision Service Post surgery opioid prescribing (Guidelines) June 2023

117 Hyland, S.J., Brockhaus, K.K., Vincent, W.R., et al., Perioperative pain management and opioid stewardship: a practical guide, 2021. In Healthcare (Vol. 9, No. 3, p. 333). MDPI.available at: Perioperative Pain Management and Opioid Stewardship: A Practical Guide

118 Levy N., Quinlan J., El-Boghdadly K., et al., An international multidisciplinary consensus statement on the prevention of opioid-related harm in adult surgical patients. Anaesthesia. 2021;76(4):520-536. doi:10.1111/anae.15262

119 McAnally, H., 2017. Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol. Perioperative medicine, 6(1), p.19. available at:

Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol | Perioperative Medicine

120 Srivastava, D., Hill, S., Carty, S., et al., Surgery and opioids: evidence-based expert consensus guidelines on the perioperative use of opioids in the United Kingdom. 2021, British Journal of Anaesthesia, 126(6), pp.1208-1216.

121 Faculty of Pain Medicine, Surgery and Opioids: Best Practice Guidelines 2021

122 Public Health Scotland Acute hospital activity and NHS beds information (annual) September 2024

123 OECD/European Commission, Health at a Glance: Europe 2024: State of Health in the EU Cycle, 2024. Paris: OECD Publishing. 10.1787/b3704e14-en.

124 Raymond, A., Watt, T., Douglas, H. R., et al., Health inequalities in 2040. Current and projected patterns of illness by deprivation in England, 2024, The Health Foundation.

125 Lucyk, K., & McLaren, L., Taking stock of the social determinants of health: a scoping review. PLoS ONE, 2017; 12(5), e0177306. 10.1371/journal.pone.0177306

126 McCartney, G., Dickie, E., Escobar, O., and Collins, C., Health inequalities, fundamental causes and power: towards the practice of good theory. Sociology of Health and Illness, 2020; 43(1), 20–39. 10.1111/1467-9566.13181

127 National Institute for Health and Care Excellence, NICE and Health Inequalities, 2024

128 Krauth, S. J., Steell, L., Ahmed, S., et al., Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohorts. eClinicalMedicine, 2024; 74, 10.1016/j.eclinm.2024.102703

129 Stannard, S., Holland, E., Crozier, S. R., et al., Early-onset burdensome multimorbidity: an exploratory analysis of sentinel conditions, condition accrual sequence and duration of three long-term conditions using the 1970 British Cohort Study. BMJ. 2022; 10.1136/bmjopen-2021-059587

130 Roberts, A., & Richards, G. C., Is England facing an opioid epidemic? British Journal of Pain, 2023; 17(3)10.1177/20494637231160684

131 Torrance, N., Veluchamy, A., Zhou, Y., et al., Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. British Journal of Anaesthesia, 2020; 125(2), 159. 10.1016/j.bja.2020.05.017

132 Woodward, A., Davies, N., Walters, K., et al., Self-management of multiple long-term conditions: A systematic review of the barriers and facilitators amongst people experiencing socioeconomic deprivation. PloS One, 2023; 18(2), e0282036. 10.1371/journal.pone.0282036

133 Craig, K. D., Holmes, C., Hudspith, M., et al., Pain in persons who are marginalized by social conditions. Pain, 2019; 161(2)10.1097/j.pain.0000000000001719

134 Macgregor, C., Walumbe, J., Tulle, E., et al., Intersectionality as a theoretical framework for researching health inequities in chronic pain. British Journal of Pain, 2023; 17(5)10.1177/20494637231188583

135 Scottish Government, Scottish Health Survey 2022 main report – volume 1, 2023.

136 Public Health England, Chronic pain in adults 2017. Health survey for England, 2020.

137 Fayaz, A., Croft, P., Langford, R. M., et al., Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open, 2016; 6(6), e010364. 10.1136/bmjopen-2015-010364

138 Keogh, E., The gender context of pain. Health Psychology Review, 2021; 15(3), 454–481. 10.1080/17437199.2020.1813602

139 Gatchel, R. J., Peng, Y. B., Peters, M. L., et al., The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychological Bulletin, 2007; 133(4), 581. 10.1037/0033-2909.133.4.581

140 Pincus, T., Kim Burton, A., Vogel, S., and Field, A. P., A Systematic Review of Psychological Factors as Predictors of Chronicity/Disability in Prospective Cohorts of Low Back Pain. Spine, 2002; 27(5)10.1097/00007632-200203010-00017

141 Hughes, K., Bellis, M. A., Hardcastle, K. A., et al., The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Public Health, 2017; 2, e356–e366.

142 Allen, J., Balfour, R., Bell, R., and Marmot, M., Social determinants of mental health. International Review of Psychiatry, 2014; 26(4), 392–407. 10.3109/09540261.2014.928270

143 Doebl, S., Macfarlane, G. J., and Hollick, R. J., “No one wants to look after the fibro patient”. Understanding models, and patient perspectives, of care for fibromyalgia: reviews of current evidence. Pain, 2020; 161(8)10.1097/j.pain.0000000000001870

144 Macgregor, C., Blane, D. N., Tulle, E., et al., An ecosystem of accepting life with chronic pain: A meta-ethnography. British Journal of Pain, 2024; 18(4)10.1177/20494637241250271

145 Toye, F., Seers, K., Allcock, N., et al., Patients’ experiences of chronic non-malignant musculoskeletal pain: a qualitative systematic review. British Journal of General Practice, 2013; 63(617), e829. 10.3399/bjgp13x675412

146 Cheetham, M., Moffatt, S., Addison, M., and Wiseman, A., Impact of Universal Credit in North East England: a qualitative study of claimants and support staff. BMJ. 2019; 10.1136/bmjopen-2019-029611

147 Morgan, C. L., Conway, P., and Currie, C. J., The relationship between self‐reported severe pain and measures of socio‐economic disadvantage. European Journal of Pain, 2011; 15(10), 1107. 10.1016/j.ejpain.2011.04.010

148 Farmer, C., Fenu, E., O’flynn, N., and Guthrie, B., Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ. 2016; 10.1136/bmj.i4843

149 May, C. R., Eton, D. T., Boehmer, K., et al., Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Services Research, 2014; 14(1), 281. 10.1186/1472-6963-14-281

150 Smith, J. A., and Osborn, M., Pain as an assault on the self: An interpretative phenomenological analysis of the psychological impact of chronic benign low back pain. Psychology and Health, 2007; 22(5), 517. 10.1080/14768320600941756

151 Webster, F., Connoy, L., Sud, A., et al., Chronic struggle: an institutional ethnography chronic pain and marginalization. 2023, The Journal of Pain, 24(3), 437–448. 10.1016/j.jpain.2022.10.004

152 Blane, D., Lunan, C., Bogie, J., et al., Tackling the inverse care law in Scottish General Practice Policies, interventions and the Scottish Deep End Project. University of Glasgow, University of Edinburgh, 2024.

153 Jain, S., Jadwani, V., Spogmy, S., and Walumbe, J. Inequalities and inequities in the types of chronic pain services available in areas of differing deprivation across England. Scandinavian Journal of Pain, 2022; 23(1), 168–174. 10.1515/sjpain-2022-0015

154 Moore, F. R., Williams, L., and Dunbar, M., Sociodemographic predictors of attendance at a Scottish pain management programme. British Journal of Pain, 2021; 15(4), 393–400. 10.1177/2049463720970579

155 Dixon-Woods, M., Cavers, D., Agarwal, S., et al., Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Medical Research Methodology, 2006; 6(1), 35. 10.1186/1471-2288-6-35

156 Robertson, R., Blythe, N., and Jeffries, D. Tackling health inequalities on NHS waiting lists, 2023, The Kings Fund.

157 Arthritis and Musculoskeletal Alliance. Act Now: Musculoskeletal Health Inequalities and Deprivation, 2024.

158 Gkiouleka, A., Wong, G., Sowden, S., et al., Reducing health inequalities through general practice: a realist review and action framework. Health and Social Care Delivery Research, 2024; 12(7)10.3310/ytww7032

159 Metzl, J. M., and Hansen, H., Structural competency: Theorizing a new medical engagement with stigma and inequality. Social Science and Medicine, 2013; 103, 126. 10.1016/j.socscimed.2013.06.032

160 Laskawska, M. S., Hébert, H. L., Richardson, C., et al., The core minimum dataset for measuring pain outcomes in pain services across Scotland. Developing and testing a brief multi-dimensional questionnaire. British Journal of Pain, 2022; 16(5), 504–517. 10.1177/20494637221092907

161 Lunn, A. D., Lynch, H., Bilaal, A., et al., What works: Addressing inequalities in the primary and secondary outpatient interface, Health Equity Centre, 2024.

162 Baker, R., Freeman, G. K., Haggerty, J. L., et al., Primary medical care continuity and patient mortality: a systematic review. British Journal of General Practice, 2020; 70(698), e600. 10.3399/bjgp20x712289

163 Palmer, W., Hemmings, N., Rosen, R., et al., Improving access and continuity in general practice Evidence review, 2018, Nuffield Trust.

164 Dickie, E., Hearty, W., Fraser, A., et al., Power – a health and social justice issue, 2015. Edinburgh: NHS Scotland.

165 Protheroe, J., Brooks, H., Chew-Graham, C., et al., ‘Permission to participate?’ A qualitative study of participation in patients from differing socio-economic backgrounds. Journal of Health Psychology, 2012; 18(8)10.1177/1359105312459876

166 Brady, B., Veljanova, I., & Chipchase, L., An exploration of the experience of pain among culturally diverse migrant communities. Rheumatology Advances in Practice, 2017; 1(1), rkx002. 10.1093/rap/rkx002

167 Brady, B., Veljanova, I., & Chipchase, L., The Intersections of Chronic Noncancer Pain: Culturally Diverse Perspectives on Disease Burden. Pain Medicine, 2019; 20(3), 434–445. 10.1093/pm/pny088s

168 Browne, A. J., Varcoe, C., Ford-Gilboe, M., et al., Disruption as opportunity: Impacts of an organizational health equity intervention in primary care clinics. International Journal for Equity in Health, 2018; 17(1)10.1186/s12939-018-0820-2

169 Walters, R., Leslie, S. J., Polson, R., et al., Establishing the efficacy of interventions to improve health literacy and health behaviours: a systematic review. BMC Public Health, 2020; 20(1)10.1186/s12889-020-08991-0

170 World Health Organisation, Health Literacy, 2024.

171 Brady, B., Andary, T., Pang, S. M., et al., A Mixed-Methods Investigation into Patients’ Decisions to Attend an Emergency Department for Chronic Pain. Pain Medicine, 2021; 22(10)10.1093/pm/pnab081

172 Lacey, R. J., Campbell, P., Lewis, M., and Protheroe, J., The Impact of Inadequate Health Literacy in a Population with Musculoskeletal Pain. HLRP: Health Literacy Research and Practice, 2018; 2(4)10.3928/24748307-20181101-01

173 Mackey, L. M., Doody, C., Werner, E. L., and Fullen, B., Self-Management Skills in Chronic Disease Management. Medical Decision Making, 2016; 36(6)10.1177/0272989x16638330

174 Mackey, L. M., Blake, C., Casey, M., et al., The impact of health literacy on health outcomes in individuals with chronic pain: a cross-sectional study. Physiotherapy, 2019; 105(3)10.1016/j.physio.2018.11.006

175 NHS England, Health literacy 'how to' guide, 2020.

176 Scottish Government, Making it Easier - a health literacy action plan, 2017.

177 Truong, M., & Fenton, S., Understanding the Current Landscape of Health Literacy Interventions within Health Systems. Perspectives in Health Information Management, 2022; 15(19)PMID: 35692852 PMCID: PMC9123532

178 NHS Education Scotland and Scottish Government, Scottish Psychological Trauma Training Plan, 2019.

179 Substance Abuse and Mental Health Services Administration. SAMHSA’s Concept of Trauma and Guidance for a Trauma-Informed Approach, 2014, HHS Publication No. (SMA) 14-4884. RockVille, MD, USA: Substance Abuse and Mental Health Services Administration.

180 Gopal, D. P., Hunter, M., Butler, D., et al., Trauma-informed care: what does it mean for general practice? British Journal of General Practice, 2023; 73(730), 229. 10.3399/bjgp23x732837

181 Purkey, E., Patel, R., and Phillips, S. P., Trauma-informed care: Better care for everyone. Canadian Family Physician, 2018; 64(3), 170–172.

182 Karran, E. L., Cashin, A. G., Barker, T., et al., The ‘what’ and ‘how’ of screening for social needs in healthcare settings: a scoping review. PeerJ, 2023; 11, e15263. 10.7717/peerj.15263

183 Brcic, V., Eberdt, C., and Kaczorowski, J., Development of a Tool to Identify Poverty in a Family Practice Setting: A Pilot Study. International Journal of Family Medicine, 2011, 812182–7. 10.1155/2011/812182

184 Public Health Scotland, Financial Inclusion referral Pathways, 2024.

185 Improvement Service, Welfare Advice and Health Partnerships, 2024.

186 Healthcare Improvement Scotland, The Quality Framework for Community Engagement and Participation, 2023. (last accessed 7 February 2025)

187 Scottish Palliative Care Guidelines Group, Scottish Palliative Care Guidelines, 2019.

188 World Health Organization Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings. 2009.

189 Woody, G.E., Kampman, K.K., Auriacombe, M., Disorders due to Substance Use: Opioids and Opioid Addiction, 2024. In: Tasman, A., et al. Tasman’s Psychiatry. Springer, Cham.

190 Laupacis A., Sackett D., Roberts R., An Assessment of Clinically Useful Measures of the Consequences of Treatment. New England Journal of Medicine. 1988;318(26):1728-1733

191 Cook R., Sackett D., The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310(6977):452-454

192 McAlister, F.A., The “number needed to treat” turns 20—and continues to be used and misused. Cmaj, 2008; 179(6), pp.549-553.

193 Guthrie B., Thompson A., Dumbreck S., et al., Better guidelines for better care: accounting for multimorbidity in clinical guidelines – structured examination of exemplar guidelines and health economic modelling. Health Serv Deliv Res 2017;5(16).